- Home
- ESCA vs KPTI Comparison
ESCA vs KPTI Comparison
Compare ESCA & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESCA | KPTI |
|---|---|---|
| Founded | 1922 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.9M | 172.6M |
| IPO Year | 1995 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ESCA | KPTI |
|---|---|---|
| Price | $17.30 | $7.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $17.50 |
| AVG Volume (30 Days) | 35.7K | ★ 603.2K |
| Earning Date | 05-04-2026 | 02-12-2026 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | ★ 6.45 | N/A |
| EPS | ★ 0.99 | N/A |
| Revenue | ★ $180,541,000.00 | $146,067,000.00 |
| Revenue This Year | $2.87 | N/A |
| Revenue Next Year | N/A | $46.62 |
| P/E Ratio | $17.76 | ★ N/A |
| Revenue Growth | ★ 2.71 | 0.57 |
| 52 Week Low | $11.41 | $3.51 |
| 52 Week High | $18.40 | $10.99 |
Technical Indicators
Market Signals| Indicator | ESCA | KPTI |
|---|---|---|
| Relative Strength Index (RSI) | 67.10 | 40.32 |
| Support Level | $13.64 | $7.15 |
| Resistance Level | N/A | $7.81 |
| Average True Range (ATR) | 0.80 | 0.79 |
| MACD | 0.21 | -0.21 |
| Stochastic Oscillator | 77.51 | 7.83 |
Price Performance
Historical ComparisonAbout ESCA Escalade Incorporated
Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).